Neovacs Is A French Biotechnology Company Founded In 1993 And Based In Paristhe Company Specializes In Developing Therapeutic Vaccines Aimed At Treating Autoimmuneinflammatoryallergyand Cancer Diseasesneovacs Operates Primarily In France And The United Statesfocusing On Immunotherapy Through Its Proprietary Kinoid Technologywhich Induces An Antibody Response In Patients The Company S Product Pipeline Includes Several Kinoidsthe Ifna Kinoid Is Currently In Phase Iib Clinical Trials For Lupus Erythematosus And Phase Iia Trials For Dermatomyositisthe Il 4 Il 13 Kinoid Is In The Preclinical Stage For Allergy Treatmentadditionallyneovacs Is Developing Tnf Kinoidsifn Kinoidsand Vegf Kinoids For Conditions Like Crohnae S Disease And Rheumatoid Arthritis Neovacs Also Engages In Investment Activitiesfocusing On Innovative Biotech And Medtech Companiesincluding A Joint Venture With Stellar Biotechnologies Incto Create Neostellwhere Neovacs Holds A 70Stakethe Company Is Committed To Advancing Immunotherapy And Innovation In The Biotech Sector
No conferences found for this company.
| Company Name | Neovacs Sa |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
